-
1
-
-
67651247638
-
Siderophores as drug delivery agents: Application of the 'Trojan Horse' strategy
-
U. Möllmann et al. Siderophores as drug delivery agents: application of the 'Trojan Horse' strategy Biometals 22 2009 615 624
-
(2009)
Biometals
, vol.22
, pp. 615-624
-
-
Möllmann, U.1
-
2
-
-
67651247598
-
Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin 'Trojan Horse' antibiotics and synthetic desferridanoxamine-antibiotic conjugates
-
T.A. Wencewicz et al. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin 'Trojan Horse' antibiotics and synthetic desferridanoxamine-antibiotic conjugates Biometals 22 2009 633 648
-
(2009)
Biometals
, vol.22
, pp. 633-648
-
-
Wencewicz, T.A.1
-
3
-
-
59449105814
-
Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents
-
M.J. Miller et al. Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents Biometals 22 2009 61 75
-
(2009)
Biometals
, vol.22
, pp. 61-75
-
-
Miller, M.J.1
-
4
-
-
0027945605
-
Microbial iron transport
-
M.L. Guerinot Microbial iron transport Ann. Rev. Microbiol. 48 1994 743 772
-
(1994)
Ann. Rev. Microbiol.
, vol.48
, pp. 743-772
-
-
Guerinot, M.L.1
-
5
-
-
0038579427
-
Bacterial iron homeostasis
-
S.C. Andrews et al. Bacterial iron homeostasis FEMS Microbiol. Rev. 27 2003 215 237
-
(2003)
FEMS Microbiol. Rev.
, vol.27
, pp. 215-237
-
-
Andrews, S.C.1
-
6
-
-
77951981537
-
Chemistry and biology of siderophores
-
R.C. Hider, and X. Kong Chemistry and biology of siderophores Nat. Prod. Rep. 27 2010 637 657
-
(2010)
Nat. Prod. Rep.
, vol.27
, pp. 637-657
-
-
Hider, R.C.1
Kong, X.2
-
7
-
-
0028850367
-
Siderophores: Structure and function of microbial iron transport compounds
-
J.B. Neilands Siderophores: structure and function of microbial iron transport compounds J. Biol. Chem. 270 1995 26723 26726
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 26723-26726
-
-
Neilands, J.B.1
-
9
-
-
34548739613
-
Siderophore-based iron acquisition and pathogen control
-
M. Miethke, and M.A. Marahiel Siderophore-based iron acquisition and pathogen control Microbiol. Mol. Biol. Rev. 71 2007 3413 3451
-
(2007)
Microbiol. Mol. Biol. Rev.
, vol.71
, pp. 3413-3451
-
-
Miethke, M.1
Marahiel, M.A.2
-
10
-
-
21844449490
-
Siderophore-mediated chemistry and microbial uptake of plutonium
-
M.P. Neu Siderophore-mediated chemistry and microbial uptake of plutonium Los Alamos Sci. 26 2000 416 417
-
(2000)
Los Alamos Sci.
, vol.26
, pp. 416-417
-
-
Neu, M.P.1
-
11
-
-
33847147545
-
Complexation of Pu(IV) with the natural siderophore desferrioxamine B and the redox properties of Pu(IV) siderophore complexes
-
H. Boukhalfa et al. Complexation of Pu(IV) with the natural siderophore desferrioxamine B and the redox properties of Pu(IV) siderophore complexes Inorg. Chem. 46 2007 1018 1026
-
(2007)
Inorg. Chem.
, vol.46
, pp. 1018-1026
-
-
Boukhalfa, H.1
-
12
-
-
35348830385
-
Iron chelation equilibria, redox, and siderophore activity of a saccharide platform ferrichrome analogue
-
S. Dhungana et al. Iron chelation equilibria, redox, and siderophore activity of a saccharide platform ferrichrome analogue Inorg. Chem. 46 2007 8362 8371
-
(2007)
Inorg. Chem.
, vol.46
, pp. 8362-8371
-
-
Dhungana, S.1
-
13
-
-
70350766680
-
Iron metabolism: A promising target for antibacterial strategies
-
M. Ballouche et al. Iron metabolism: a promising target for antibacterial strategies Recent Pat. Antiinfect. Drug Discov. 4 2009 190 205
-
(2009)
Recent Pat. Antiinfect. Drug Discov.
, vol.4
, pp. 190-205
-
-
Ballouche, M.1
-
14
-
-
46149094595
-
New substrates for TonB-dependent transport: Do we only see the 'tip of the iceberg'?
-
K. Schauer et al. New substrates for TonB-dependent transport: do we only see the 'tip of the iceberg'? Trends Biochem. Sci. 33 2008 330 338
-
(2008)
Trends Biochem. Sci.
, vol.33
, pp. 330-338
-
-
Schauer, K.1
-
15
-
-
0034079929
-
Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA
-
A.D. Ferguson et al. Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA Protein Sci. 9 2000 956 963
-
(2000)
Protein Sci.
, vol.9
, pp. 956-963
-
-
Ferguson, A.D.1
-
16
-
-
59449092463
-
Sideromycins: Tools and antibiotics
-
V. Braun et al. Sideromycins: tools and antibiotics Biometals 22 2009 3 13
-
(2009)
Biometals
, vol.22
, pp. 3-13
-
-
Braun, V.1
-
18
-
-
34548724460
-
Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria
-
J. Lubelski et al. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria Microbiol. Mol. Biol. Rev. 71 2007 463 476
-
(2007)
Microbiol. Mol. Biol. Rev.
, vol.71
, pp. 463-476
-
-
Lubelski, J.1
-
19
-
-
0037853294
-
Tertiary structure of bacterial murein: The scaffold model
-
B.A. Dmitriev et al. Tertiary structure of bacterial murein: the scaffold model J. Bacteriol. 185 2003 3458 3468
-
(2003)
J. Bacteriol.
, vol.185
, pp. 3458-3468
-
-
Dmitriev, B.A.1
-
20
-
-
84875454942
-
Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus
-
T.A. Wencewicz et al. Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus Bioconjug. Chem. 24 2013 473 486
-
(2013)
Bioconjug. Chem.
, vol.24
, pp. 473-486
-
-
Wencewicz, T.A.1
-
21
-
-
84885382019
-
Curb challenges of the 'Trojan Horse' approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery
-
Y. Huang et al. Curb challenges of the 'Trojan Horse' approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery Adv. Drug Deliv. Rev. 65 2013 1299 1315
-
(2013)
Adv. Drug Deliv. Rev.
, vol.65
, pp. 1299-1315
-
-
Huang, Y.1
-
22
-
-
40049103479
-
Design and synthesis of a novel protected mixed ligand siderophore
-
P. Ding et al. Design and synthesis of a novel protected mixed ligand siderophore Tetrahedron Lett. 49 2008 2306 2310
-
(2008)
Tetrahedron Lett.
, vol.49
, pp. 2306-2310
-
-
Ding, P.1
-
23
-
-
84867393274
-
Syntheses of siderophore-drug conjugates using a convergent thiol-maleimide system
-
R.E. Juárez-Hernández et al. Syntheses of siderophore-drug conjugates using a convergent thiol-maleimide system ACS Med. Chem. Lett. 3 2012 799 803
-
(2012)
ACS Med. Chem. Lett.
, vol.3
, pp. 799-803
-
-
Juárez-Hernández, R.E.1
-
24
-
-
0029962175
-
Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates
-
M. Ghosh, and M.J. Miller Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates Bioorg. Med. Chem. 4 1996 43 48
-
(1996)
Bioorg. Med. Chem.
, vol.4
, pp. 43-48
-
-
Ghosh, M.1
Miller, M.J.2
-
25
-
-
84878035473
-
Biscatecholate-monohydroxamate mixed ligand siderophore- carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii
-
T.A. Wencewicz, and M.J. Miller Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii J. Med. Chem. 23 2013 4044 4052
-
(2013)
J. Med. Chem.
, vol.23
, pp. 4044-4052
-
-
Wencewicz, T.A.1
Miller, M.J.2
-
26
-
-
84862509089
-
Iron transport-mediated drug delivery: Practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore-aminopenicillin conjugates reveals selectively potent antipseudomonal activity
-
C. Ji et al. Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore- aminopenicillin conjugates reveals selectively potent antipseudomonal activity J. Am. Chem. Soc. 134 2012 9898 9901
-
(2012)
J. Am. Chem. Soc.
, vol.134
, pp. 9898-9901
-
-
Ji, C.1
-
27
-
-
80054124262
-
Medical applications of siderophores
-
B. Nagoba, and D. Vedpathak Medical applications of siderophores Eur. J. Gen. Med. 8 2011 229 235
-
(2011)
Eur. J. Gen. Med.
, vol.8
, pp. 229-235
-
-
Nagoba, B.1
Vedpathak, D.2
-
29
-
-
0026728122
-
Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria
-
A. Brochu et al. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria Antimicrob. Agents Chemother. 36 2001 2166 2175
-
(2001)
Antimicrob. Agents Chemother.
, vol.36
, pp. 2166-2175
-
-
Brochu, A.1
-
30
-
-
0034044581
-
Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents
-
J.M. Roosenberg et al. Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents Curr. Med. Chem. 7 2000 159 197
-
(2000)
Curr. Med. Chem.
, vol.7
, pp. 159-197
-
-
Roosenberg, J.M.1
-
31
-
-
0035352559
-
Siderophore-antibiotic conjugates used as trojan horses against Pseudomonas aeruginosa
-
H. Budzikiewicz Siderophore-antibiotic conjugates used as trojan horses against Pseudomonas aeruginosa Curr. Top. Med. Chem. 1 2001 73 82
-
(2001)
Curr. Top. Med. Chem.
, vol.1
, pp. 73-82
-
-
Budzikiewicz, H.1
-
32
-
-
10344230917
-
Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria
-
M.S. Diarra et al. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria Antimicrob. Agents Chemother. 40 1996 2610 2617
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 2610-2617
-
-
Diarra, M.S.1
-
33
-
-
84887943889
-
Synthesis of carbohydrate-based artificial siderophores and their biological applications
-
A.P. Rauter, T. Lindhorst, Royal Society of Chemistry
-
M.M. Andrade, and A.P. Rauter Synthesis of carbohydrate-based artificial siderophores and their biological applications A.P. Rauter, T. Lindhorst, Carbohydrate Chemistry 2012 Royal Society of Chemistry 398 415
-
(2012)
Carbohydrate Chemistry
, pp. 398-415
-
-
Andrade, M.M.1
Rauter, A.P.2
-
34
-
-
0030453553
-
Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates
-
A. Ghosh et al. Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates Chem. Biol. 3 1996 1011 1019
-
(1996)
Chem. Biol.
, vol.3
, pp. 1011-1019
-
-
Ghosh, A.1
-
35
-
-
79960880056
-
Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4
-
M.R. Seyedsayamdost et al. Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4 J. Am. Chem. Soc. 133 2011 11434 11437
-
(2011)
J. Am. Chem. Soc.
, vol.133
, pp. 11434-11437
-
-
Seyedsayamdost, M.R.1
-
36
-
-
29844457587
-
The evolution of iron chelators for the treatment of iron overload disease and cancer
-
D.S. Kalinowski, and D.R. Richardson The evolution of iron chelators for the treatment of iron overload disease and cancer Pharmacol. Rev. 57 2005 547 583
-
(2005)
Pharmacol. Rev.
, vol.57
, pp. 547-583
-
-
Kalinowski, D.S.1
Richardson, D.R.2
-
37
-
-
77956126203
-
Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation
-
Y. Liu et al. Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation Antimicrob. Agents Chemother. 54 2010 3960 3963
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 3960-3963
-
-
Liu, Y.1
-
38
-
-
2142824217
-
Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously
-
C. Llanes et al. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously Antimicrob. Agents Chemother. 48 2004 1797 1802
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 1797-1802
-
-
Llanes, C.1
-
39
-
-
0034426126
-
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
-
N. Masuda et al. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 44 2000 3322 3327
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 3322-3327
-
-
Masuda, N.1
-
40
-
-
0031750326
-
The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway
-
O. Kinzel et al. The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway J. Antibiot. (Tokyo) 51 1998 499 507
-
(1998)
J. Antibiot. (Tokyo)
, vol.51
, pp. 499-507
-
-
Kinzel, O.1
-
41
-
-
84877655609
-
Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics
-
S.J. Milner et al. Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics Org. Biomol. Chem. 11 2013 3461 3468
-
(2013)
Org. Biomol. Chem.
, vol.11
, pp. 3461-3468
-
-
Milner, S.J.1
-
42
-
-
24944457520
-
Iron chelation therapy
-
C.M. Hershko et al. Iron chelation therapy Curr. Hematol. Rep. 4 2005 110 116
-
(2005)
Curr. Hematol. Rep.
, vol.4
, pp. 110-116
-
-
Hershko, C.M.1
-
43
-
-
0041808770
-
Mechanism of iron toxicity
-
A. Pietrangelo Mechanism of iron toxicity Adv. Exp. Med. Biol. 509 2002 19 43
-
(2002)
Adv. Exp. Med. Biol.
, vol.509
, pp. 19-43
-
-
Pietrangelo, A.1
-
44
-
-
79952488109
-
Application of magnetic particles in pharmaceutical sciences
-
M.P. Marszałł Application of magnetic particles in pharmaceutical sciences Pharm. Res. 28 2011 480 483
-
(2011)
Pharm. Res.
, vol.28
, pp. 480-483
-
-
Marszałł, M.P.1
-
45
-
-
67650672138
-
Biomedical applications of distally controlled magnetic nanoparticles
-
J.L. Corchero, and A. Villaverde Biomedical applications of distally controlled magnetic nanoparticles Trends Biotechnol. 27 2009 468 476
-
(2009)
Trends Biotechnol.
, vol.27
, pp. 468-476
-
-
Corchero, J.L.1
Villaverde, A.2
-
46
-
-
79952485717
-
Biomagnetic methods: Technologies applied to pharmaceutical research
-
A. Luciana et al. Biomagnetic methods: technologies applied to pharmaceutical research Pharm. Res. 28 2011 438 455
-
(2011)
Pharm. Res.
, vol.28
, pp. 438-455
-
-
Luciana, A.1
-
47
-
-
84964884284
-
The development of magnetic drug delivery and disposition
-
A.A. Hashim, InTech
-
M.P. Marszałł The development of magnetic drug delivery and disposition A.A. Hashim, The Delivery of Nanoparticles 2012 InTech 95 110
-
(2012)
The Delivery of Nanoparticles
, pp. 95-110
-
-
Marszałł, M.P.1
-
48
-
-
84862658644
-
Magnetic nanoparticles in magnetic resonance imaging and diagnostics
-
Ch. Rumenapp et al. Magnetic nanoparticles in magnetic resonance imaging and diagnostics Pharm. Res. 29 2012 1165 1179
-
(2012)
Pharm. Res.
, vol.29
, pp. 1165-1179
-
-
Rumenapp, Ch.1
-
49
-
-
61349139614
-
Drug delivery and nanoparticles: Applications and hazards
-
W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles: applications and hazards Int. J. Nanomedicine 3 2008 133 149
-
(2008)
Int. J. Nanomedicine
, vol.3
, pp. 133-149
-
-
De Jong, W.H.1
Borm, P.J.2
-
50
-
-
34548507968
-
Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae
-
A. Pramanik et al. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae Int. J. Med. Microbiol. 297 2007 459 469
-
(2007)
Int. J. Med. Microbiol.
, vol.297
, pp. 459-469
-
-
Pramanik, A.1
-
52
-
-
42449155111
-
The evolution of gene collectives: How natural selection drives chemical innovation
-
M.A. Fischbach et al. The evolution of gene collectives: how natural selection drives chemical innovation Proc. Natl. Acad. Sci. U.S.A. 105 2008 4601 4608
-
(2008)
Proc. Natl. Acad. Sci. U.S.A.
, vol.105
, pp. 4601-4608
-
-
Fischbach, M.A.1
-
53
-
-
0037971906
-
Solid-phase synthesis of methyl carboxymycobactin T 7 and analogues as potential antimycobacterial agents
-
A.R. Poreddy et al. Solid-phase synthesis of methyl carboxymycobactin T 7 and analogues as potential antimycobacterial agents Bioorg. Med. Chem. Lett. 13 2003 2553 2556
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, pp. 2553-2556
-
-
Poreddy, A.R.1
-
54
-
-
0032574771
-
Lipophilic siderophores of mycobacterium tuberculosis prevent cardiac reperfusion injury
-
L.D. Horwitz et al. Lipophilic siderophores of mycobacterium tuberculosis prevent cardiac reperfusion injury Proc. Natl. Acad. Sci. U.S.A. 95 1998 5263 5268
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 5263-5268
-
-
Horwitz, L.D.1
-
55
-
-
27144560152
-
Combined therapy with deferiprone and desferrioxamine in thalassemia major
-
R. Origa et al. Combined therapy with deferiprone and desferrioxamine in thalassemia major Haematologica 90 2005 1309 1314
-
(2005)
Haematologica
, vol.90
, pp. 1309-1314
-
-
Origa, R.1
-
56
-
-
0031001278
-
Iron-chelating therapy and the treatment of thalassemia
-
N.F. Olivieri, and G.M. Brittenham Iron-chelating therapy and the treatment of thalassemia Blood 89 1997 739 761
-
(1997)
Blood
, vol.89
, pp. 739-761
-
-
Olivieri, N.F.1
Brittenham, G.M.2
-
57
-
-
84864943245
-
Desferrioxamine attenuates pancreatic injury after major hepatectomy under vascular control of the liver: Experimental study in pigs
-
P. Varsos et al. Desferrioxamine attenuates pancreatic injury after major hepatectomy under vascular control of the liver: experimental study in pigs HPB Surg. 2012 2012 714672
-
(2012)
HPB Surg.
, vol.2012
, pp. 714672
-
-
Varsos, P.1
-
58
-
-
0020774896
-
Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis
-
L. Kremp et al. Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis Arch. Fr. Pediatr. 40 1983 475 477
-
(1983)
Arch. Fr. Pediatr.
, vol.40
, pp. 475-477
-
-
Kremp, L.1
-
59
-
-
0344392914
-
Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy
-
T. Yang et al. Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy J. Lab. Clin. Med. 142 2003 332 340
-
(2003)
J. Lab. Clin. Med.
, vol.142
, pp. 332-340
-
-
Yang, T.1
-
60
-
-
0037323129
-
Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy
-
C.A. Obejero-Paz et al. Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy J. Lab. Clin. Med. 141 2003 121 130
-
(2003)
J. Lab. Clin. Med.
, vol.141
, pp. 121-130
-
-
Obejero-Paz, C.A.1
-
61
-
-
0042575616
-
The protective and therapeutic effects of zinc chloride and desferrioxamine on skin exposed to nitrogen mustard
-
T. Karayilanoǧlu et al. The protective and therapeutic effects of zinc chloride and desferrioxamine on skin exposed to nitrogen mustard Mil. Med. 168 2003 614 617
-
(2003)
Mil. Med.
, vol.168
, pp. 614-617
-
-
Karayilanoǧlu, T.1
-
62
-
-
0037297556
-
Preventative effect of deferoxamine on degenerative changes in the optic nerve in experimental retrobulbar haematoma
-
A. Pelit et al. Preventative effect of deferoxamine on degenerative changes in the optic nerve in experimental retrobulbar haematoma Clin. Experiment. Ophthalmol. 31 2003 66 72
-
(2003)
Clin. Experiment. Ophthalmol.
, vol.31
, pp. 66-72
-
-
Pelit, A.1
-
63
-
-
0037232582
-
Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model
-
V.S. Chekanov et al. Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model Ann. Thorac. Surg. 75 2003 184 189
-
(2003)
Ann. Thorac. Surg.
, vol.75
, pp. 184-189
-
-
Chekanov, V.S.1
-
64
-
-
0027194737
-
Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle
-
G.A. Fantini, and T. Yoshioka Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle Am. J. Physiol. 264 1993 1953 1959
-
(1993)
Am. J. Physiol.
, vol.264
, pp. 1953-1959
-
-
Fantini, G.A.1
Yoshioka, T.2
-
65
-
-
7244239197
-
Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: A link between iron metabolism and proliferation
-
N.T. Le, and D.R. Richardson Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation Blood 104 2004 2967 2975
-
(2004)
Blood
, vol.104
, pp. 2967-2975
-
-
Le, N.T.1
Richardson, D.R.2
|